vs
Side-by-side financial comparison of Dynatrace, Inc. (DT) and Bio-Techne (TECH). Click either name above to swap in a different company.
Dynatrace, Inc. is the larger business by last-quarter revenue ($515.5M vs $295.9M, roughly 1.7× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 7.8%, a 5.1% gap on every dollar of revenue. On growth, Dynatrace, Inc. posted the faster year-over-year revenue change (18.2% vs -6.4%). Over the past eight quarters, Dynatrace, Inc.'s revenue compounded faster (16.3% CAGR vs 4.2%).
Dynatrace, Inc. is an American multinational technology company that provides an AI-powered observability platform. Their software is used to monitor, analyze, and optimize application performance, software development, cyber security practices, IT infrastructure, and user experience.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
DT vs TECH — Head-to-Head
Income Statement — Q3 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $515.5M | $295.9M |
| Net Profit | $40.1M | $38.0M |
| Gross Margin | 81.4% | 64.6% |
| Operating Margin | 14.1% | 18.4% |
| Net Margin | 7.8% | 12.8% |
| Revenue YoY | 18.2% | -6.4% |
| Net Profit YoY | -88.9% | 68.3% |
| EPS (diluted) | $0.13 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $515.5M | $295.9M | ||
| Q3 25 | $493.8M | — | ||
| Q2 25 | $477.3M | $317.0M | ||
| Q1 25 | $445.2M | $316.2M | ||
| Q4 24 | $436.2M | $297.0M | ||
| Q3 24 | $418.1M | $289.5M | ||
| Q2 24 | $399.2M | $306.1M | ||
| Q1 24 | $380.8M | $303.4M |
| Q4 25 | $40.1M | $38.0M | ||
| Q3 25 | $57.2M | — | ||
| Q2 25 | $48.0M | $-17.7M | ||
| Q1 25 | $39.3M | $22.6M | ||
| Q4 24 | $361.8M | $34.9M | ||
| Q3 24 | $44.0M | $33.6M | ||
| Q2 24 | $38.6M | $40.6M | ||
| Q1 24 | $37.9M | $49.1M |
| Q4 25 | 81.4% | 64.6% | ||
| Q3 25 | 81.8% | — | ||
| Q2 25 | 82.1% | 62.7% | ||
| Q1 25 | 80.9% | 67.9% | ||
| Q4 24 | 81.1% | 65.3% | ||
| Q3 24 | 81.4% | 63.2% | ||
| Q2 24 | 81.3% | 66.4% | ||
| Q1 24 | 81.1% | 67.4% |
| Q4 25 | 14.1% | 18.4% | ||
| Q3 25 | 14.8% | — | ||
| Q2 25 | 13.1% | -7.5% | ||
| Q1 25 | 9.6% | 12.2% | ||
| Q4 24 | 10.9% | 16.0% | ||
| Q3 24 | 11.2% | 13.8% | ||
| Q2 24 | 10.5% | 15.0% | ||
| Q1 24 | 6.1% | 22.1% |
| Q4 25 | 7.8% | 12.8% | ||
| Q3 25 | 11.6% | — | ||
| Q2 25 | 10.0% | -5.6% | ||
| Q1 25 | 8.8% | 7.1% | ||
| Q4 24 | 82.9% | 11.7% | ||
| Q3 24 | 10.5% | 11.6% | ||
| Q2 24 | 9.7% | 13.3% | ||
| Q1 24 | 10.0% | 16.2% |
| Q4 25 | $0.13 | $0.24 | ||
| Q3 25 | $0.19 | — | ||
| Q2 25 | $0.16 | $-0.11 | ||
| Q1 25 | $0.12 | $0.14 | ||
| Q4 24 | $1.19 | $0.22 | ||
| Q3 24 | $0.15 | $0.21 | ||
| Q2 24 | $0.13 | $0.26 | ||
| Q1 24 | $0.13 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $2.7B | $2.0B |
| Total Assets | $4.1B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.2B | $172.9M | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $162.2M | ||
| Q1 25 | $1.1B | $140.7M | ||
| Q4 24 | $1.0B | $177.5M | ||
| Q3 24 | $1.0B | $187.5M | ||
| Q2 24 | $1.0B | $152.9M | ||
| Q1 24 | $836.9M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $2.7B | $2.0B | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.7B | $1.9B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.6B | $2.1B | ||
| Q3 24 | $2.1B | $2.1B | ||
| Q2 24 | $2.1B | $2.1B | ||
| Q1 24 | $2.0B | $2.0B |
| Q4 25 | $4.1B | $2.5B | ||
| Q3 25 | $4.1B | — | ||
| Q2 25 | $4.1B | $2.6B | ||
| Q1 25 | $4.1B | $2.6B | ||
| Q4 24 | $3.7B | $2.7B | ||
| Q3 24 | $3.3B | $2.7B | ||
| Q2 24 | $3.3B | $2.7B | ||
| Q1 24 | $3.4B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $33.8M | — |
| Free Cash FlowOCF − Capex | $27.2M | — |
| FCF MarginFCF / Revenue | 5.3% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | 0.84× | — |
| TTM Free Cash FlowTrailing 4 quarters | $465.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $33.8M | — | ||
| Q3 25 | $32.0M | — | ||
| Q2 25 | $269.7M | $98.2M | ||
| Q1 25 | $162.8M | $41.1M | ||
| Q4 24 | $42.2M | $84.3M | ||
| Q3 24 | $23.6M | $63.9M | ||
| Q2 24 | $230.7M | $75.5M | ||
| Q1 24 | $131.7M | $81.0M |
| Q4 25 | $27.2M | — | ||
| Q3 25 | $27.8M | — | ||
| Q2 25 | $262.2M | $93.3M | ||
| Q1 25 | $148.2M | $31.0M | ||
| Q4 24 | $37.6M | $77.5M | ||
| Q3 24 | $20.1M | $54.7M | ||
| Q2 24 | $227.4M | $57.5M | ||
| Q1 24 | $121.9M | $64.5M |
| Q4 25 | 5.3% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 54.9% | 29.4% | ||
| Q1 25 | 33.3% | 9.8% | ||
| Q4 24 | 8.6% | 26.1% | ||
| Q3 24 | 4.8% | 18.9% | ||
| Q2 24 | 57.0% | 18.8% | ||
| Q1 24 | 32.0% | 21.3% |
| Q4 25 | 1.3% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.6% | 1.5% | ||
| Q1 25 | 3.3% | 3.2% | ||
| Q4 24 | 1.1% | 2.3% | ||
| Q3 24 | 0.8% | 3.2% | ||
| Q2 24 | 0.8% | 5.9% | ||
| Q1 24 | 2.6% | 5.4% |
| Q4 25 | 0.84× | — | ||
| Q3 25 | 0.56× | — | ||
| Q2 25 | 5.62× | — | ||
| Q1 25 | 4.14× | 1.82× | ||
| Q4 24 | 0.12× | 2.42× | ||
| Q3 24 | 0.54× | 1.90× | ||
| Q2 24 | 5.97× | 1.86× | ||
| Q1 24 | 3.47× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DT
| Subscription And Circulation | $493.4M | 96% |
| Services | $22.1M | 4% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
